PUBLISHER: GlobalData | PRODUCT CODE: 1410793
PUBLISHER: GlobalData | PRODUCT CODE: 1410793
Biopsy Devices Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033 is built to visualize quantitative market trends within General Surgery Devices therapeutic area.
The model discusses in detail the impact of COVID-19 on Biopsy Devices market for the year 2020 and beyond. A biopsy device is an instrument that aids in the removal of tissue samples from the body. Increasing global cancer incidence is one of the primary drivers of the biopsy devices market. Increasing prevalence results in a growing need for effective diagnostic procedures, which in turn, impacts market growth. Demand for the minimal invasive procedure has also contributed to the biopsy devices market. Advances in technology, especially biopsy devices with improved features such as enhanced accuracy, quicker recovery of patients, and less traumatic procedures, will result in safer procedures. Government programs to promote diagnosis is expected to improve the utilization of diagnostic devices.
Each of the covered 39 country's color-coded and fully-sourced market models are equipped with epidemiology based indications with procedure volumes. To increase the data transparency, the interactive excel deliverable covers installed base, new sales volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.
Key Inclusions of the market model are -
Currently marketed Biopsy Devices and evolving competitive landscape -
Global, Regional and Country level market specific insights -
Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.
Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.
Companies covered: Becton Dickinson and Co, Danaher Corp, Hologic Inc, Cook Group Inc, Boston Scientific Corp, Medtronic Plc, ConMed Corp, Olympus Corp, Weigao Group Co Ltd, Henry Schein Inc, Coloplast A/S, Merit Medical Systems Inc, Integra LifeSciences Holdings Corp, Teleflex Inc, Acuderm Inc, Steris Plc, and Others.
Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina, and Chile.
This Market Model gives important, expert insight you won't find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for -
The model will enable you to -
Not Applicable
Not Applicable
Not Applicable